Wood Tarver Financial Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-751
Closed -$34K 215
2025
Q2
$34K Buy
751
+66
+10% +$3.24K 0.01% 308
2025
Q1
$41.8K Buy
685
+1
+0.1% +$58 0.01% 284
2024
Q4
$38K Buy
+684
New +$38.2K 0.01% 284

Other funds holding BMY

Wood Tarver Financial Group's BMY Position: Q3 2025 in Review

Wood Tarver Financial Group sold out of Bristol-Myers Squibb (BMY) in Q3 2025, closing a stake of 751 shares — an estimated $34K sold.

Wood Tarver Financial Group first reported a position in BMY in Q4 2024 and held it in 3 quarters. The position peaked at $41.8K in Q1 2025. 2,267 funds tracked by Wall St. Rank hold BMY as of Q3 2025.

  • Wood Tarver Financial Group reported no remaining Bristol-Myers Squibb position as of Q3 2025 after selling out during the quarter.
  • Wood Tarver Financial Group sold 751 Bristol-Myers Squibb shares in Q3 2025, an estimated $34K.
  • Wood Tarver Financial Group first reported a position in Bristol-Myers Squibb in Q4 2024 and held it in 3 quarters.
  • Wood Tarver Financial Group's Bristol-Myers Squibb position peaked at $41.8K in Q1 2025.
  • 2,267 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.

Based on Wood Tarver Financial Group's 13F filing for Q3 2025, filed 14 Nov 2025.